Vasküler Giriş Yolları

1. Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK:
Type of vascular access and mortality in US hemodialysis patients.
Kidney Int 2001; 60: 1443-1451
2. Pastan S, Soucie JM, McClellan WM: Vascular access and increased
risk of death among hemodialysis patients. Kidney Int 2002; 62:
620-626
3. Xue JL, Dahl D, Ebben JP, Collins AJ: The association of initial
hemodialysis access type with mortality outcomes in elderly
Medicare ESRD patients. Am J Kidney Dis 2003; 42: 1013-1019
4. Rayner HC, Besarab A, Brown WW, Disney A, Saito A, Pisoni RL:
Vascular access results from the Dialysis Outcomes and Practice
Patterns Study (DOPPS): Performance Against Kidney Disease
Outcomes Quality Initiative (K/DOQI) Clinical Practice Guidelines.
Am J Kidney Dis 2004; 44: 22-26
5. Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG: Vascular
access and all-cause mortality: A propensity score analysis. J Am
Soc Nephrol 2004; 15: 477-486
6. Astor BC, Eustace JA, Powe NR, Klag MJ, Fink NE, Coresh J:
Type of vascular access and survival among incident hemodialysis
patients: The Choices for Healthy Outcomes in Caring for ESRD
(CHOICE) Study. J Am Soc Nephrol 2005; 16: 1449-1455
7. Lorenzo V, Martin M, Rufi no M, Hernandez D, Torres A, Ayus JC:
Predialysis nephrologic care and a functioning arteriovenous fi stula
at entry are associated with better survival in incident hemodialysis
patients: An observational cohort study. Am J Kidney Dis 2004; 43:
999-1007
8. Bradbury BD, Fissell RB, Albert JM, Anthony MS, Critchlow CW,
Pisoni RL, Port FK, Gillespie BW: Predictors of early mortality
among incident United States hemodialysis patients in the Dialysis
Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc
Nephrol 2007; 2: 89-99
9. Feldman HI, Kobrin S, Wasserstein A: Hemodialysis vascular
access morbidity. J Am Soc Nephrol 1996; 7: 523-535
10. Dixon BS, Novak L, Fangman J: Hemodialysis vascular access
survival: Upper-arm native arteriovenous fi stula. Am J Kidney Dis
2002; 39: 92-101
11. Huber TS, Carter JW, Carter RL, Seeger JM: Patency of autogenous
and polytetrafl uoroethylene upper extremity arteriovenous
hemodialysis accesses: A systematic review. J Vasc Surg 2003; 38:
1005-1011
12. Pisoni RL, Young EW, Dykstra DM, Greenwood RN, Hecking E,
Gillespie B, Wolfe RA, Goodkin DA, Held PJ: Vascular access use
in Europe and the United States: Results from the DOPPS. Kidney
Int 2002; 61: 305-316
213
Yelken B ve Sever M Ş: Vasküler Giriş Yolları
Türk Nefroloji Diyaliz ve Transplantasyon Dergisi
Turkish Nephrology, Dialysis and Transplantation Journal
Turk Neph Dial Transpl 2011; 20 (3): 209-213
13. Pisoni RL, Arrington CJ, Albert JM, Ethier J, Kimata N, Krishnan
M, Rayner HC, Saito A, Sands JJ, Saran R, Gillespie B, Wolfe RA,
Port FK: Facility hemodialysis vascular access use and mortality in
countries participating in DOPPS: an instrumental variable analysis.
Am J Kidney Dis 2009; 53(3): 475-491
14. Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK:
Type of vascular access and mortality in U.S. hemodialysis patients.
Kidney Int 2001; 60(4): 1443-1451
15. Astor BC, Eustace JA, Powe NR, Klag MJ, Fink NE, Coresh J:
Type of vascular access and survival among incident hemodialysis
patients: The Choices for Healthy Outcomes in Caring for ESRD
(CHOICE) Study. J Am Soc Nephrol 2005; 16(5): 1449-1455
16. Eggers P, Chen SC, Ebben J, Collins A: A Fistula is the Least
Expensive Form of Vascular Access in Terms of Total Medicare
Expenditures: A CPM Cohort Study United States Renal Data
System, 2003
17. Manns B, Tonelli M, Yilmaz S, Lee H, Laupland K, Klarenbach
S, Radkevich V, Murphy B: Establishment and maintenance of
vascular access in incident hemodialysis patients: A prospective
cost analysis. J Am Soc Nephrol 2005; 16: 201-209
18. NKF-DOQI clinical practice guidelines for vascular Access:
National Kidney Foundation-Dialysis Outcomes Quality Initiative.
Am J Kidney Dis 1997; 30: 150-191
19. NKF-KDOQI: Clinical practice guidelines for vascular access. Am
J Kidney Dis 2006; 48 (Suppl 1): 248-272
20. Besarab A: Vascular access in Europe and the US: Striking contrasts.
Contemp Dial Nephrol 1999; 20: 22-28
21. Ethier J, Mendelssohn DC, Elder SJ, Hasegawa T, Akizawa T, Akiba
T, Canaud BJ, Pisoni RL: Vascular access use and outcomes: An
international perspective from the Dialysis Outcomes and Practice
Patterns Study. Nephrol Dial Transplant 2008; 23(10): 3219-3226
22. Erek E, Serdengeçti K, Süleymanlar G, (eds): Registry of the
nephrology, dialysis and transplantation in Turkey. İstanbul: Türk
Nefroloji Derneği, 2007
23. Sever MS, Doğan C, Yazici H, Yilmaz M, Calıskan Y, Yelken
BM, Ok E, Bascı A: Vascular access practice in a large cohort of
hemodialysis patients, data from EuCLiD, Turkey. Turk Neph Dial
Transpl 2009; 18: 29 (OP-025)
24. Hakim RM, Himmelfarb J: Hemodialysis access failure: A call to
action-revisited. Kidney Int 2009; 76(10): 1040-1048
25. Astor BC, Eustace JA, Powe NR, Klag MJ, Sadler JH, Fink NE,
Coresh J: Timing of nephrologist referral and arteriovenous access
use: The CHOICE Study. Am J Kidney Dis 2001; 38: 494-501
26. Dixon BS: Why don’t fi stulas mature? Kidney Int 2006; 70:
1413-1422
27. Lok CE, Allon M, Moist L, Oliver MJ, Shah H, Zimmerman D:
Risk equation determining unsuccessful cannulation events and
failure to maturation in arteriovenous fi stulas (REDUCE FTM I). J
Am Soc Nephrol 2006; 17: 3204-3212
28. Lee D, Levin A, Roger SD, McMahon LP: Longitudinal analysis of
performance of estimated glomerular fi ltration rate as renal function
declines in chronic kidney disease. Nephrol Dial Transplant 2009;
24: 109-116
29. Levin A: Identifi cation of patients and risk factors in chronic kidney
disease evaluating risk factors and therapeutic strategies. Nephrol
Dial Transplant 2001; 16 (Suppl 7): 57-60
30. Rehman R, Schmidt RJ, Moss AH: Ethical and legal obligation to
avoid long-term tunneled catheter access. Clin J Am Soc Nephrol
2009; 4: 456-460
31. Dember LM, Beck GJ, Allon M, Delmez JA, Dixon BS, Greenberg
A, Himmelfarb J, Vazquez MA, Gassman JJ, Greene T, Radeva
MK, Braden GL, Ikizler TA, Rocco MV, Davidson IJ, Kaufman JS,
Meyers CM, Kusek JW, Feldman HI: Effect of clopidogrel on early
failure of arteriovenous fi stulas for hemodialysis: A randomized
controlled trial. JAMA 2008; 299(18): 2164-2171
32. Hasegawa T, Elder SJ, Bragg-Gresham JL, Pisoni RL, Yamazaki S,
Akizawa T, Jadoul M, Hugh RC, Port FK, Fukuhara S: Consistent
aspirin use associated with improved arteriovenous fi stula survival
among incident hemodialysis patients in the dialysis outcomes
and practice patterns study. Clin J Am Soc Nephrol 2008; 3(5):
1373-1378